.svg)
Akkermansia sp004167065: A Species-Level View Inside the Genus
An Akkermansia sp004167065 test measures the relative amount of this specific Akkermansia species in your stool using DNA sequencing. Labs typically use 16S rRNA profiling or shotgun metagenomics to determine which microbes are present and in what proportions. The “sp004167065” label comes from genome-based taxonomy systems that distinguish closely related species. In practical terms, this helps separate different Akkermansia lineages that may behave slightly differently in the gut ecosystem. Your result reflects a snapshot in time of your current microbial balance, not a fixed trait.
Why this matters: Akkermansia species dwell near the intestinal mucus layer, feeding on mucin and helping stimulate healthy mucus turnover. Through this role, they influence digestion, the gut barrier, and immune tone. They produce metabolites like acetate and propionate that can support other beneficial bacteria, which in turn generate butyrate for colon cell energy. Research links Akkermansia to metabolic health and lower inflammation in many cohorts, though more research is needed to define species-specific effects. Patterns of steady presence and diversity across the microbiome generally signal gut resilience.
Why a Species-Level Look Adds Signal
Connecting biology to daily life: Akkermansia sits at the interface of your food, your mucus layer, and your immune system. Too little may coincide with a thinner, less dynamic mucus layer and more erratic barrier function; too much in a very low-fiber context may signal the microbiome is leaning on mucin for fuel rather than fermenting dietary fibers. Testing helps you see where you stand. It can shed light on digestive symptoms, shifts after antibiotics, restrictive eating patterns, or stressful periods that change sleep and recovery. It is especially useful when you are troubleshooting persistent GI issues, noticing changes in weight or glucose responses, or evaluating how a new nutrition plan is affecting your gut environment.
Zooming out, the gut microbiome influences glucose regulation, low-grade inflammation, body composition, and even mood through the gut–brain axis. Repeated testing lets you track how sustained habits like fiber variety, polyphenol-rich foods, strength training, and better sleep architecture relate to microbial stability and function. The aim is not a perfect number. The goal is to understand your signature pattern and how it shifts over time so you and your clinician can make informed, preventive decisions for long-term health.
What Your Akkermansia sp004167065 Number Actually Says
Your Akkermansia sp004167065 result is reported as a proportion of total microbial DNA, sometimes alongside a percentile compared to a reference population. Many healthy adults show a detectable but modest level of Akkermansia, though there is wide normal variation between individuals and across diets and geographies. Higher overall microbiome diversity and a balanced presence of beneficial genera (for example, Bifidobacterium and Faecalibacterium) often accompany a more stable gut environment in which Akkermansia plays a supportive role.
If your Akkermansia sits in an “optimal for you” range, that often aligns with efficient fermentation, good short-chain fatty acid dynamics, and a calm immune tone. Practically, this may translate to steadier digestion and less reactivity to everyday foods. There is no universal target for everyone, and individual set points can differ based on genetics, routine fiber and polyphenol intake, and cultural dietary patterns.
If your level is low or absent, it may point to a less active mucus turnover cycle or a microbiome that is not well supported by fermentable substrates. If it is relatively high in the setting of low dietary fiber, it may indicate greater reliance on mucin as fuel. These patterns are not diagnoses. They highlight mechanisms worth exploring with your clinician, such as fiber diversity, meal timing relative to workouts, and stress–sleep cycles that shape gut motility and immune signaling. Emerging research associates a steady Akkermansia presence with favorable metabolic markers, but clinical decisions should rest on your full history and standard medical testing.
Where This Number Fits in Your Bigger Picture
Big picture, Akkermansia data becomes more meaningful when integrated with other biomarkers and your story over time. For example, pairing this result with inflammatory markers, glucose metrics, liver enzymes, or stool inflammation measures can clarify whether gut barrier support is translating into systemic calm. Keep in mind key limitations: stool reflects the lumen more than the mucosal surface where Akkermansia resides; sequencing methods and databases can classify species differently; DNA capture reflects presence but not real-time activity; recent antibiotics, colonoscopy prep, acute illness, or shipping delays can shift results. When interpreted alongside your diet, symptoms, and lifestyle, an Akkermansia sp004167065 test can help personalize your approach to digestion, energy, and long-term metabolic health.
FAQs
The Akkermansia sp004167065 Test analyzes the genetic material of bacteria, fungi, and other microorganisms in a stool sample to identify species diversity, relative abundance, and potential functional capabilities of the microbial community.
Results describe the composition and balance of the gut microbiome—what organisms are present, in what amounts, and what functions they may have—but they indicate microbial balance rather than diagnosing or proving the presence of disease.
The akkermansia sp004167065 test is a simple, at‑home stool collection: you collect a small stool sample using the swab or vial provided in the kit, seal the sample as directed, and prepare it for return to the lab.
Maintain cleanliness (wash hands before and after, avoid touching the interior of the swab or vial), clearly label the sample with the required information, and follow the kit instructions exactly for collection, storage, and shipping—these steps are essential to avoid contamination and ensure accurate sequencing results.
Akkermansia sp004167065 test results — typically showing presence and relative abundance — can give clues about several aspects of gut-related health: digestion (role in mucus layer maintenance and gut barrier function), inflammation (associations with lower or higher inflammatory markers depending on context), nutrient absorption and short‑chain fatty acid production (influencing energy harvest and micronutrient interactions), metabolism (links observed with body weight regulation and glucose metabolism), and gut–brain communication (microbial metabolites and immune signaling that may affect mood and cognition).
These patterns can suggest areas to investigate but are not diagnostic: microbiome findings correlate with but do not prove specific diseases or causes, and should be interpreted alongside clinical history, symptoms, and other laboratory tests by a healthcare professional.
Next‑generation sequencing provides high-resolution microbial data and can detect and quantify taxa such as Akkermansia sp004167065, but interpretation of an Akkermansia sp004167065 Test is probabilistic—detection and relative-abundance estimates depend on sequencing depth, sample handling, reference databases, and bioinformatic methods, so results indicate likelihoods and relative signals rather than absolute, definitive counts.
Test results reflect a snapshot in time and may change with short‑term factors; diet, stress, illness or bowel habits, and recent antibiotic use can all alter the detected abundance, so repeated sampling or clinical context is often needed to determine the result’s significance.
Many people test their akkermansia sp004167065 once per year to establish a baseline, or more frequently—about every 3–6 months—if they are actively adjusting diet, taking probiotics, or making other interventions that could affect levels.
What matters most is comparing trends over time rather than relying on a single reading, so use the same testing method and similar timing for repeat tests to track meaningful changes.
Microbial populations, including those of akkermansia sp004167065, can change within days in response to dietary or lifestyle shifts (for example changes in fiber intake, antibiotics, sleep, or travel), but more consistent, stable patterns typically emerge over weeks to months as the gut community re-establishes itself.
For meaningful comparisons between tests, try to keep diet and lifestyle consistent for several weeks before retesting—day-to-day variation is common, so longer-term stability gives a clearer picture of true population changes.
References
- Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., de Vos, W. M., & Cani, P. D. (2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America, 110(22), 9066-9071. https://doi.org/10.1073/pnas.1219451110
- Durazzi, F., Sala, C., Castellani, G., Manfreda, G., Remondini, D., & De Cesare, A. (2021). Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota. Scientific Reports, 11, 3030. https://doi.org/10.1038/s41598-021-82726-y
- Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell, 165(6), 1332-1345. https://doi.org/10.1016/j.cell.2016.05.041
- Lynch, S. V., & Pedersen, O. (2016). The human intestinal microbiome in health and disease. The New England Journal of Medicine, 375(24), 2369-2379. https://doi.org/10.1056/NEJMra1600266
- Porcari, S., Mullish, B. H., Asnicar, F., Ng, S. C., Zhao, L., Hansen, R., O'Toole, P. W., Raes, J., Hold, G., Putignani, L., Gasbarrini, A., Segata, N., & Cammarota, G. (2025). International consensus statement on microbiome testing in clinical practice. The Lancet Gastroenterology & Hepatology, 10(2), 154-167. https://doi.org/10.1016/S2468-1253(24)00311-X
.avif)
.svg)
.svg)
